In Situ Immunomodulation With CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients w/ Unresectable and Metastatic Solid Tumors
University of Southern California
University of Southern California
Var2 Pharmaceuticals
Valo Therapeutics Oy
NextPoint Therapeutics, Inc.
Instituto do Cancer do Estado de São Paulo
Stanford University
National Cancer Institute (NCI)
BioEclipse Therapeutics
Cellestia Biotech AG
Celgene
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Masonic Cancer Center, University of Minnesota
Novartis
City of Hope Medical Center
Valerio Therapeutics
Valerio Therapeutics
INSYS Therapeutics Inc
Dartmouth-Hitchcock Medical Center
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
Case Comprehensive Cancer Center